Matthew M.Y

Jan 24, 2025 | eprints.gla.ac.uk | Matthew M.Y

Sattar, N. and Lee, M. M.Y. (2025) Estimating direct (tissue effects) versus weight loss effects of incretin-based anti-obesity medicines on differing chronic conditions: a viewpoint.

Jan 16, 2025 | eprints.gla.ac.uk | Matthew M.Y

Codina, P., Lee, M. M.Y. , Tomasoni, D. and Aimo, A. (2024) What's new in heart failure? December 2024. European Journal of Heart Failure, 26(12), pp. 2477-2481. (doi: 10.1002/ejhf.3553) (PMID:39739985) Full text not currently available from Enlighten. AbstractThis issue of the European Journal of Heart Failure features pioneering research addressing some of the most critical challenges in heart failure (HF) management.

Jan 10, 2025 | eprints.gla.ac.uk | John J.V |Matthew M.Y

Osmanska, J. et al. (2025) Cardiovascular magnetic resonance-estimated pulmonary capillary wedge pressure, congestion markers, and effect of empagliflozin in patients with heart failure with reduced ejection fraction and dysglycaemia (SUGAR-DM-HF). European Journal of Heart Failure, (doi: 10.1002/ejhf.3570) (PMID:39792133) (Early Online Publication)Text343617.pdf - Published Version Available under License Creative Commons Attribution.

Nov 25, 2024 | eprints.gla.ac.uk | John J.V |Katriona J.M |M. Mitchell |Matthew M.Y

Docherty, K. F. et al. (2024) Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI). European Journal of Heart Failure, (Accepted for Publication)Text343035.pdf - Accepted Version Restricted to Repository staff only386kBAbstractNo abstract available.

Nov 8, 2024 | eprints.gla.ac.uk | Matthew M.Y |John J.V

Osmanska, J., Petrie, M. C. , Docherty, K. F. , Lee, M. M.Y. , McMurray, J. J.V. and Campbell, R. (2024) Subcutaneous furosemide in heart failure: a systematic review. European Heart Journal: Cardiovascular Pharmacotherapy, (doi: 10.1093/ehjcvp/pvae083) (Accepted for Publication)Text340966.pdf - Accepted Version Available under License Creative Commons Attribution.